A Bluebird Bio gene therapy has helped children with a devastating neurological disorder, but seven have developed blood ...

A new technology enables the control of specific brain circuits non-invasively with magnetic fields, according to a ...

John Maraganore, the former CEO of Alnylam Pharmaceuticals, launched City Therapeutics, a new startup with $135 million from ...

A new gene drive can copy and paste itself into the genomes of herpes simplex viruses in mice. The end goal is a version that disables the virus in humans.

Two biotechs set out for the public markets this week, with Upstream Bio raising $255 million for its inflammatory disease ...

Researchers will develop therapies for urea cycle disorders and create a platform to rapidly develop treatments for other rare genetic disorders.

Upstream Bio has swollen its IPO to $255 million as the company joins CAMP4 Therapeutics this morning in becoming the latest ...

Six years ago, Sanofi gave $125 million and promised over $1 billion in milestone payments to buzzy neuroscience startup ...

The offering will fund testing of a potential rival to Amgen’s Tezpire and is already the sixth for an immune drug developer this year, the most since 2021.

The Psychobiological Approach to Couple Therapy® is a cohesive approach derived from research in three areas: developmental neuroscience, attachment theory, and arousal regulation. Neuroscience ...

Hurricane Milton Is Linked to 11 Deaths, Many Far From Landfall Rescuers pulled scores of people from flooded or damaged buildings and vehicles on Thursday after Hurricane Milton tore across ...

BrucePac recalls 9.9 million pounds of ready-to-eat meat and poultry products due to potential listeria contamination discovered during USDA testing. Though no illnesses are reported yet, symptoms ...